Panacea Index Logo

Command Palette

Search for a command to run...

Analysis of hepatic gene expression profile in a spontaneous mouse model of type 2 diabetes under a high sucrose diet.

Endocrine journal
January 1, 2013
Koji Nojima et al. (6 authors)
Journal ArticleResearch Support, Non-U.S. Gov'tAnimal Study
Extracted Claims (12)
InterventionDirectionEndpointPopulationDosageImpactClaim #
high-fat diet (HFD)
increase
body weight gain
C3H mice
-
significantly increased
#1
high-fat diet (HFD)
no change
glucose tolerance
C3H mice
-
maintained
#2
high-sucrose diet (HSD)
increase
body weight gain
NSY mice
-
increased
#3
high-sucrose diet (HSD)
increase
liver steatosis
NSY mice
-
increased
#4
high-sucrose diet (HSD)
increase
glucose intolerance
NSY mice
to a greater extent than HFD
increased
#5
high-sucrose diet (HSD)
increase
hepatic expression levels of Pparg2
NSY mice
-
exhibited increased
#6
high-sucrose diet (HSD)
increase
hepatic expression levels of G0s2
NSY mice
-
exhibited increased
#7
high-sucrose diet (HSD)
decrease
hepatic expression levels of Kat2b
NSY mice
-
further decreased
#8
high-sucrose diet (HSD)
decrease
hepatic expression levels of Hsd3b5
NSY mice
-
further decreased
#9
high-sucrose diet (HSD)
decrease
hepatic expression levels of Cyp7b1
NSY mice
-
further decreased
#10
-
decrease
Expression of Metallothionein (Mt1)
NSY mice
-
significantly lower
#11
-
decrease
Expression of Metallothionein 2 (Mt2)
NSY mice
-
significantly lower
#12
Abstract

Both genetic factors and diabetogenic environmental factors, such as a high-sucrose diet (HSD), are involved in the development of type 2 diabetes. In this study, the Nagoya-Shibata-Yasuda (NSY) mouse, an animal model of type 2 diabetes and C3H mice used as controls, were fed a HSD, a high-fat diet (HFD) or a regular diet (RD) from weaning. In C3H mice, HFD significantly increased body weight gain, but maintained glucose tolerance. In contrast, in NSY mice, HSD resulted in increased body weight gain and liver steatosis and increased glucose intolerance to a greater extent than HFD. Furthermore, we performed DNA microarray analysis to detect differences in hepatic gene expression levels in both strains under HSD. We then performed RT-PCR analysis on selected genes to evaluate basal expression level under RD and changes under HSD conditions. HSD-fed NSY, but not C3H mice, exhibited increased hepatic expression levels of Pparg2, an isoform of Pparg as well as G0s2, a target of Pparg, which are known to be adipocyte-specific genes. Compared to RD-fed C3H mice, hepatic expression levels of Kat2b (transcriptional regulation), Hsd3b5 (steroid hormone metabolism) and Cyp7b1 (bile acid metabolism) were initially lower in RD-fed NSY mice, and were further decreased in HSD-fed NSY mice. Expression of Metallothionein (Mt1) and Metallothionein 2 (Mt2) was significantly lower in NSY mice compared to C3H mice, irrespective of dietary condition. These data suggest that elucidation of this heterogeneity in response to HSD might contribute to further understanding of the gene-environment interactions leading to diabetes in humans.

Medical Subject Headings (MeSH)
AnimalsDiabetes Mellitus, Type 2Diet, High-FatDietary SucroseDisease Models, AnimalFatty LiverGlucose IntoleranceGlucose Tolerance TestInsulinInsulin ResistanceLiverMiceMice, Inbred C3HOligonucleotide Array Sequence AnalysisPancreasPolymerase Chain ReactionTranscriptomeWeight Gain
Study Links
PubMed ID23131898
Related Supplements